SC Filed 2024-11-18 Event — SEC 0000895345-24-000586 →

Boxer Capital Management, LLC → iTeos Therapeutics, Inc.

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

8 13D/G filings on this issuer

7 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on iTeos Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2025-09-03	SCHEDULE	TANG CAPITAL MANAGEMENT LLC	100.00%	10,000	view →
2025-05-19	SCHEDULE	RA CAPITAL MANAGEMENT, L.P.	4.90%	2,134,806	view →
2025-05-14	SCHEDULE	RA CAPITAL MANAGEMENT, L.P.	9.90%	4,163,276	view →
2022-01-06	SC	Boxer Capital, LLC	—	—	view →
2021-12-10	SC	MPM BioVentures 2014, L.P.	—	—	view →
2021-10-19	SC	MPM BioVentures 2014, L.P.	—	—	view →
2021-09-21	SC	MPM BioVentures 2014, L.P.	—	—	view →

Other Filings by Boxer Capital Management, LLC

Filed	Form	Issuer	Stake	Shares
2026-07-10	SCHEDULE 13G	Q32 Bio Inc. QTTB	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →